Clinical Trial Update: Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/3 trial assessing tacrolimus plus intravenous immunoglobulins for Rasmussen Encephalitis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rasmussen Encephalitis

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Rasmussen Encephalitis | Phase 2, Phase 3 | Status: UNKNOWN